March 12, 2020 / 1:47 PM / 18 days ago

BRIEF-Vir Biotechnology Announces Intent To Collaborate With Biogen On Manufacturing Of Antibodies To Potentially Treat Covid-19

March 12 (Reuters) - Vir Biotechnology Inc:

* VIR BIOTECHNOLOGY ANNOUNCES INTENT TO COLLABORATE WITH BIOGEN ON MANUFACTURING OF ANTIBODIES TO POTENTIALLY TREAT COVID-19

* VIR BIOTECHNOLOGY - CO, BIOGEN HAVE BEGUN WORK WHILE A CLINICAL DEVELOPMENT AND MANUFACTURING AGREEMENT IS BEING NEGOTIATED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below